Dechra Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Dechra Pharmaceuticals heeft een totaal eigen vermogen van £755.2M en een totale schuld van £487.6M, wat de schuld-eigenvermogensverhouding op 64.6% brengt. De totale activa en totale passiva bedragen respectievelijk £1.6B en £814.2M. De EBIT Dechra Pharmaceuticals is £17.1M waardoor de rentedekking 0.8 is. Het heeft contanten en kortetermijnbeleggingen van £74.4M.
Belangrijke informatie
64.6%
Verhouding schuld/eigen vermogen
UK£487.60m
Schuld
| Rente dekkingsratio | 0.8x |
| Contant | UK£74.40m |
| Aandelen | UK£755.20m |
| Totaal verplichtingen | UK£814.20m |
| Totaal activa | UK£1.57b |
Recente financiële gezondheidsupdates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( £467.9M ) DPH } overtreffen de korte termijn passiva ( £164.0M ).
Langlopende schulden: De kortetermijnactiva van DPH ( £467.9M ) dekken de langetermijnschulden ( £650.2M ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 54.7% ) DPH wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van DPH is de afgelopen 5 jaar gestegen van 57.6% naar 64.6%.
Schuldendekking: De schuld van DPH wordt niet goed gedekt door de operationele kasstroom ( 13% ).
Rentedekking: De rentebetalingen van DPH op haar schulden worden niet goed gedekt door EBIT ( 0.8 x dekking).